ResMed's GAAP net income for 6 months of fiscal 2021 was $357.9 million, up 27.5% from $280.7 million in the prior year. Revenue increased 9.5% to $1.552 billion compared to $1.417 billion a year earlier.
ResMed's GAAP net income for 6 months of fiscal 2021 was $357.9 million, up 27.5% from $280.7 million in the prior year. Revenue increased 9.5% to $1.552 billion compared to $1.417 billion a year earlier. 
investor.resmed.com
English (US) 